Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1070 | 1022 | 1154 | 1096 | 1238 | 1549 |
Fund Return | 6.95% | 2.19% | 15.41% | 3.12% | 4.36% | 4.47% |
Place in category | 503 | 707 | 514 | 189 | 100 | 54 |
% in Category | 43 | 62 | 45 | 25 | 19 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Absolute Return Bond Fund U.S. Doll | 1.92B | 5.40 | 2.44 | 2.55 | ||
Payden Global Short Bond Fund USD A | 488.82M | 3.79 | 1.62 | 1.68 | ||
Payden Global Infl Lnkd Bd USD Acc | 99.03M | 1.23 | -5.03 | 1.91 | ||
Payden US Core Bond Fund USD Inc | 79.89M | 2.21 | -2.14 | 1.48 | ||
Payden Global Bond Fund USD Acc | 32.31M | 1.45 | -2.46 | 1.56 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Barings Umbrella Fund plc High Yiel | 4.17B | 10.42 | 4.82 | 6.17 | ||
Global High Yield Bond Fund R Acc U | 2.95B | 7.35 | 3.32 | 4.43 | ||
Global High Yield Bond Fund Adm Acc | 2.95B | 7.07 | 3.07 | 4.16 | ||
Global High Yield Bond Fund E Acc U | 2.95B | 6.70 | 2.66 | 3.75 | ||
Global High Yield Bond Fund E Inc U | 2.95B | 6.71 | 2.69 | 3.76 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
F/C Us 5yr Note (Cbt) Dec24 | - | 0.97 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 3.75% | XS2406607098 | 0.75 | - | - | |
PRA Group Inc. 8.875% | - | 0.72 | - | - | |
Kier Group PLC 9% | XS2758129949 | 0.68 | - | - | |
T/L Ttm Technolog Zcp 05/30/30 | - | 0.68 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | BUY |
Summary | Sell | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review